In vivo testing of circulating ovarian tumor cells in the contexts of both thrombocytosis and thrombocytopenia could assist in more accurately pinpointing PAI-1’s position in the metastatic cascade. The gene discussed is SERPINE1; the disease is ovarian neoplasm.